Cancer 13 , 482495 (2013)
The main difference in GHK-Cu vs BPC-157 is that GHK-Cu is more often associated with collagen and skin regeneration pathways, while BPC-157 is more often associated with tendon, ligament, muscle, gut, and systemic recovery pathways
When you inject peptides like BPC 157 over the area of pain, it does not directly go to the area of tissue damage initially
The results differ significantly by administration route: topical serum, topical post-microneedling, and supervised subcutaneous injection produce different outcomes, with injectable 503A compounded GHK-Cu producing the most consistent and comprehensive results in clinical settings
Where it comes up most often: Where it is not firmly established: That distinction matters